CAM
ASXC

Crestone Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Crestone Asset Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,520
Closed -$20K – 53
2019
Q3 		$20K Buy
+2,520
New +$34.3K 0.01% 50

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestone Asset Management's ASXC Position: Q4 2019 in Review

Crestone Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 2,520 shares — an estimated $20K sold.

Crestone Asset Management first reported a position in ASXC in Q3 2019 and held it in 1 quarter. The position peaked at $20K in Q3 2019. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

  • Crestone Asset Management reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
  • Crestone Asset Management sold 2,520 Asensus Surgical, Inc. shares in Q4 2019, an estimated $20K.
  • Crestone Asset Management first reported a position in Asensus Surgical, Inc. in Q3 2019 and held it in 1 quarter.
  • Crestone Asset Management's Asensus Surgical, Inc. position peaked at $20K in Q3 2019.
  • 81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Crestone Asset Management's 13F filing for Q4 2019, filed 12 Mar 2021.